Search

Your search keyword '"Alivernini S"' showing total 218 results

Search Constraints

Start Over You searched for: Author "Alivernini S" Remove constraint Author: "Alivernini S"
218 results on '"Alivernini S"'

Search Results

1. OP0088 ENTHESEAL TISSUE SIGNATURE IN RESPONSE TO IL-17 BLOCKADE IN PSORIATIC ARTHRITIS - RESULTS FROM THE EBIO ENTHESIAL BIOPSY STUDY

2. OP0193 BITEING MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS WITH CD19-T CELL ENGAGERS

3. OP0062 MULTI-MODAL ANALYSIS OF SYNOVIAL TISSUE MACROPHAGES INFORMS ON TREATMENT RESPONSE IN NAIVE TO TREATMENT RHEUMATOID ARTHRITIS

4. POS1172 PLASMA STREM1 AND IL-6 DETERMINATION IDENTIFY DISTINCT SUBSETS AND IMPROVE CLINICAL MANAGEMENT IN SPONDYLOARTHRITIS: A CROSS-SECTIONAL STUDY

5. Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function

6. P715 Multiparametric assessment of IBD and SpA-IBD patients to explore disease biomarkers and response predictors

10. POS1353 SEMIQUANTITATIVE ASSESSMENT OF KNEE OSTEOARTHRITIS-RELATED SYNOVITIS COMPARED TO CHRONIC INFLAMMATORY ARTHRITIDES: RELATION TO AGE AND IMPACT ON BONE/STRUCTURAL DAMAGE

11. POS0425 SINGLE-CELL RNA SEQUENCING OF SYNOVIAL TISSUE-DERIVED MYELOID CELLS IN PSORIATIC ARTHRITIS PATIENTS ACROSS DISEASE PHASES

12. POS0867 B-CELL SUBSETS IN PERIPHERAL BLOOD ACROSS DISEASE PHASES OF PSORIATIC ARTHRITIS AND THEIR CORRELATION WITH SYNOVIAL TISSUE FEATURES

13. POS0904 INTENSIVE TRAINING PROGRAM FOR ULTRASOUND-GUIDED MINIMALLY INVASIVE SYNOVIAL TISSUE BIOPSY PROCEDURE ON SMALL AND LARGE JOINTS IN DIFFERENT PHASES OF JOINT INFLAMMATION

14. POS1485 SEMIQUANTITATIVE ASSESSMENT OF SYNOVIAL INFLAMMATION ON US-GUIDED SYNOVIAL TISSUE BIOPSIES OF SYSTEMIC LUPUS ERYTHEMATOSUS COMPARED TO OTHER CONNECTIVE TISSUE DISEASES AND RHEUMATOID ARTHRITIS

15. AB0241 PATIENTS WITH RHEUMATOID ARTHRITIS AND RHEUMATOLOGISTS AGED ≤ 40 YEARS HAVE DIFFERENT PRIORITIES AND PERSPECTIVES ON DISEASE MANAGEMENT: THE ITALIAN SOCIETY FOR RHEUMATOLOGY YOUNG (SIRYOUNG) COMMISSION SURVEY

16. Postural control and disability in patients with early rheumatoid arthritis

18. RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection

19. Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48

20. Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function

21. POS0777 STUDY OF PERIPHERAL BLOOD B CELL IMMUNO-PHENOTYPING IN PATIENTS WITH LUPUS NEPHRITIS: PARAMETERS OF DISEASE ACTIVITY, REMISSION AND FLARE

23. POS0105 IMMUNOLOGICAL AND TISSUE DERIVED BIOMARKERS OF EARLY RESPONSE IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS

24. POS0316 SEMIQUANTITATIVE ASSESSMENT OF SYNOVITIS ON US-GUIDED SYNOVIAL MEMBRANE BIOPSIES IS CONTINGENT ON DISEASE PHASE AND PREDICTIVE OF TREATMENT RESPONSE IN NAIVE TO TREATMENT PSORIATIC ARTHRITIS

25. OP0084 DIGITAL SPATIAL PROFILING REVEALS DISTINCT SYNOVIAL TISSUE MACROPHAGE TRANSCRIPTOMIC SIGNATURE OF SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS PATIENTS AT RISK OF DISEASE FLARE AFTER TREATMENT CESSATION

26. Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9)

28. Seroprevalence of anti‐SARS‐CoV‐2 IgG antibodies in children with household exposure to adults with COVID‐19: Preliminary findings

29. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes

30. Telemedicine will not keep us apart in COVID-19 pandemic

31. Postural control and disability in patients with early rheumatoid arthritis

33. POS0110 ASSOCIATION OF miR-155 AND miR-34a EXPRESSION IN LUPUS NEPHRITIS RENAL TISSUE WITH DISEASE ONSET AND OUTCOMES

34. Erratum. management of adult-onset still's disease with interleukin-1 inhibitors. evidence- and consensus-based statements by a panel of Italian experts

35. Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases

36. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings

37. No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic

38. Comparative analysis of synovial inflammation after SARS-CoV-2 infection

39. Sarilumab use in severe SARS-CoV-2 pneumonia

40. Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations

42. AB1265 GENDER DISTRIBUTION AND GENDER-RELATED ISSUES AMONG YOUNG RHEUMATOLOGISTS AND ACADEMIC POSITIONS IN RHEUMATOLOGY: A SNAPSHOT OF THE CURRENT SITUATION IN ITALY

43. FRI0574 RENAL TISSUE EPIGENETIC BIOMARKERS’ CHARACTERIZATION IN PATIENTS WITH LUPUS NEPHRITIS AS PARAMETERS OF DISEASE ACTIVITY, REMISSION AND FLARE

46. SAT0027 DEVELOPMENT AND VALIDATION OF A NOMOGRAM COMBINING CLINICAL AND HISTOPATHOLOGICAL SYNOVIAL FEATURES FOR PREDICTING EARLY TREATMENT RESPONSE IN NAIVE TO TREATMENT RHEUMATOID ARTHRITIS

47. AB1234 MICRO-RNA 155 AND MIR-34A: POSSIBLE BIOMARKERS OF INFLAMMATORY BURDEN AND DISEASE ACTIVITY IN ANCA-ASSOCIATED VASCULITIS WITH RENAL INVOLVEMENT

Catalog

Books, media, physical & digital resources